Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2017-06-12
|
RiboMABs®(mRNA-encoded antibody drugs) |
|
preclinical |
BioNTech (Germany) |
|
2017-06-12
|
ADS-5102 (amantadine hydrochloride) |
levodopa-induced dyskinesia (LID) in Parkinson's disease (PD) patients |
2-3 |
Adamas Pharmaceuticals (USA - CA) |
Neurodegenerative diseases - Rare diseases |
2017-06-11
|
PQ912 |
Alzheimer’s Disease |
2a |
Probiodrug (Germany) |
Neurodegenerative diseases |
2017-06-10
|
MYL-1501D (biosimilar version of insulin glargin) |
type 1 diabetes, type 2 diabetes |
3 |
Mylan (USA - PA) Biocon (India) |
Metabolic diseases |
2017-06-10
|
ZGN-1061 |
patients with type 2 diabetes who are overweight or obese |
1 |
Zafgen (USA - MA) |
Metabolic diseases |
2017-06-10
|
ertugliflozin |
type 2 diabetes |
3 |
Merck&Co (USA - NJ) - Pfizer (USA - NY) |
Metabolic diseases |
2017-06-10
|
Soliqua®/iGlarLixi® (single injection Lyxumia®(lixisenatide) /Lantus® (insuline glargine) combination product |
diabetes |
3 |
Sanofi (France) Zealand Pharma (Denmark) |
Metabolic diseases |
2017-06-09
|
Orkambi® (lumacaftor in combination with ivacaftor ) |
cystic fibrosis |
3 |
Vertex Pharmaceuticals (USA - MA) |
Rare diseases - Genetic diseases |
2017-06-09
|
Xilonix™ |
advanced colorectal cancer |
3 |
XBiotech (USA - TX) |
Cancer - Oncology |
2017-06-09
|
Orkambi® (lumacaftor in combination with ivacaftor ) |
children with cystic fibrosis (CF) ages 6 through 11 who have two copies of the F508del mutation |
3 |
Vertex Pharmaceuticals (USA - MA) |
Rare diseases - Genetic diseases |
2017-06-09
|
Xtandi® (enzalutamide) |
non metastatic castration-resistant prostate cancer |
3 |
Medivation (USA - CA), now Pfizer (USA - NY) Astellas (Japan) |
Cancer - Oncology |
2017-06-08
|
ALKS 3831 |
schizophrenia |
3 |
Alkermes (Ireland) |
CNS diseases - Mental diseases |
2017-06-08
|
AMG 334 (erenumab) |
migraine |
3 |
Amgen (USA - CA) Novartis (Switzerland) |
CNS diseases |
2017-06-08
|
AMG 334 (erenumab) |
migraine |
3 |
Amgen (USA - CA) Novartis (Switzerland) |
CNS diseases |
2017-06-08
|
SENS-401 |
inner ear lesions |
1 |
Sensorion (France) |
Otorhinolaryngology |
2017-06-08
|
VGX-3100 |
cervical dysplasia caused by human papillomavirus (HPV) |
3 |
Inovio Pharmaceuticals (USA - PA) |
Infectious diseases - Women health - Cancer - Oncology |
2017-06-07
|
BioChaperone® Combo 75/25 |
type 2 diabetes |
1b |
Adocia (France) |
Metabolic diseases |
2017-06-07
|
CTL019 - tisagenlecleucel-T |
diffuse large B-cell lymphoma (DLBCL) |
2 |
Novartis (Switzerland) |
Cancer - Oncology |
2017-06-07
|
alidornase alfa AIR DNase™ (PRX-110) |
cystic fibrosis |
2 |
Protalix BioTherapeutics (Israel) |
Rare diseases - Genetic diseases |
2017-06-06
|
solriamfetol - JZP-110 (formerly known as ADX-N05) |
excessive sleepiness |
3 |
Jazz Pharmaceuticals (Ireland) |
Rare diseases |